Iodoquinol adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Adverse Reactions | ==Adverse Reactions== | ||
The following local adverse reactions are reported infrequently with topical corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VYTONE (HYDROCORTISONE ACETATE, IODOQUINOL) CREAM [ARTESA LABS, LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d7278ee-2c8e-4df1-9372-d43403122945 | publisher = | date = | accessdate = }}</ref> | The following local adverse reactions are reported infrequently with topical corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VYTONE (HYDROCORTISONE ACETATE, IODOQUINOL) CREAM [ARTESA LABS, LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d7278ee-2c8e-4df1-9372-d43403122945 | publisher = | date = | accessdate = }}</ref> | ||
Revision as of 20:09, 23 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Adverse Reactions
The following local adverse reactions are reported infrequently with topical corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria.[1]
References
Adapted from the FDA Package Insert.